Medicare Enrolled
Dr. Daniel Reznicek, M.D.
Urology Physician · Bellingham, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reznicek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reznicek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reznicek
Dr. Daniel Reznicek is an urology physician in Bellingham, WA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Reznicek performed 1,899 Medicare services across 1,158 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reznicek received a total of $10,679 from 66 pharmaceutical and/or device companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reznicek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 26% volume in WA
$10,679 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,899
Medicare services
Top 26% in WA for urology physician
1,158
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 499 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $90 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
197 | $59 | $152 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
116 | $8 | $41 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
104 | $55 | $427 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $109 | $342 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
98 | $2 | $11 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 81 | $135 | $765 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
46 | $24 | $201 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
43 | $22 | $58 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
32 | $87 | $457 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
31 | $123 | $655 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $43 | $91 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $76 | $224 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
25 | $91 | $764 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
23 | $8 | $26 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
20 | $70 | $228 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $89 | $1,166 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $25 | $96 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $176 | $570 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $113 | $511 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
16 | $8 | $27 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
16 | $8 | $22 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
16 | $8 | $29 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
14 | $47 | $149 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $4 | $29 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
13 | $161 | $609 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
12.6% medium
83.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,679
Total received (2018-2024)
Avg $1,526/year across 7 years
Top 10% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
407
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,437 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,598
2023
$1,495
2022
$1,729
2021
$748
2020
$905
2019
$2,101
2018
$2,103
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$350
Boston Scientific Corporation
$169
ABBVIE INC.
$160
Sumitomo Pharma America, Inc.
$138
Janssen Biotech, Inc.
$106
C. R. Bard, Inc. & Subsidiaries
$57
Astellas Pharma US Inc
$56
PFIZER INC.
$52
Endo USA, Inc.
$52
Ferring Pharmaceuticals Inc.
$50
ACCORD HEALTHCARE, INC.
$47
Becton, Dickinson and Company
$38
Dendreon Pharmaceuticals LLC
$38
Merck Sharp & Dohme LLC
$37
Laborie Medical Technologies Corp.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
Tempus AI, Inc
$26
Calyxo, Inc.
$23
Olympus America Inc.
$20
Telix Pharmaceuticals
$20
PROCEPT BioRobotics Corporation
$20
Novartis Pharmaceuticals Corporation
$20
Endo Pharmaceuticals Inc.
$18
ABC Home Medical Supply, Inc.
$17
Myriad Genetic Laboratories, Inc.
$14
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$2,845
Boston Scientific Corporation
$981
Medtronic, Inc.
$767
Janssen Biotech, Inc.
$591
Astellas Pharma US Inc
$413
Sumitomo Pharma America, Inc.
$372
PFIZER INC.
$368
Dendreon Pharmaceuticals LLC
$314
ABBVIE INC.
$294
Rochester Medical Corporation
$254
Endo Pharmaceuticals Inc.
$250
Medtronic USA, Inc.
$237
Antares Pharma, Inc.
$147
AbbVie, Inc.
$133
Bayer HealthCare Pharmaceuticals Inc.
$128
Blue Earth Diagnostics Limited
$118
Accord Healthcare, Inc.
$115
Myriad Genetic Laboratories, Inc.
$113
BOSTON SCIENTIFIC CORPORATION
$112
Coloplast Corp
$104
Progenics Pharmaceuticals, Inc.
$103
ACCORD HEALTHCARE, INC.
$96
Myovant Sciences Inc.
$85
Laborie Medical Technologies Corp.
$81
C. R. Bard, Inc. & Subsidiaries
$80
Merck Sharp & Dohme LLC
$79
Janssen Scientific Affairs, LLC
$77
Amgen Inc.
$76
TOLMAR Pharmaceuticals, Inc.
$70
UroGen Pharma, Inc.
$68
Sun Pharmaceutical Industries Inc.
$67
Ferring Pharmaceuticals Inc.
$65
COLOPLAST CORP
$58
AbbVie Inc.
$54
ConvaTec Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$53
AMAG Pharmaceuticals, Inc.
$53
Endo USA, Inc.
$52
Teleflex LLC
$49
PROCEPT BioRobotics Corporation
$49
Axonics, Inc.
$47
180 Medical, Inc.
$44
TherapeuticsMD, Inc.
$41
Allergan Inc.
$38
Becton, Dickinson and Company
$38
ABC Home Medical Supply, Inc.
$37
Travere Therapeutics, Inc.
$34
Photocure Inc
$31
Tolmar, Inc.
$28
UROVANT SCIENCES INC
$27
Tempus AI, Inc
$26
UROGEN PHARMA, INC.
$23
Calyxo, Inc.
$23
Retrophin, Inc.
$20
Olympus America Inc.
$20
Telix Pharmaceuticals
$20
Novartis Pharmaceuticals Corporation
$20
Trevena, Inc.
$20
Augmenix, Inc.
$19
Profound Medical Corp.
$17
Ambu Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
AngioDynamics, Inc.
$15
Alnylam Pharmaceuticals Inc.
$13
UroMed, Inc.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Advantage System · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · CVAC ASPIRATION SYSTEM · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL ERECTILE DYSFUNCTION · GENERAL - ERECTILE DYSFUNCTION · GENERAL - ONCOLOGY · GENTLECATH · General - Erectile Dysfunction · ILLUCCIX · IMVEXXY · INTERSTIM · INTRAROSA · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Noctiva · Nubeqa · OBTRYX · ORGOVYX · OXLUMO · Olinvyk · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PRECISETUMOR · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · Rezum Generator · SEGLENTIS · SPACEOAR VUE · SPEEDICATH · STATLOCK · SUTENT · Self Cath · SpaceOAR · SpaceOAR VUE System - 10mL · TACTRA · TOVIAZ · Thiola · Titan · Tulsa-Pro · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for urology physician in WA.
Geographic Context
Urology physicians within 10 mi
8
Per 100K population
3.5
County median income
$80,989
Nearest hospital
ST JOSEPH HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reznicek is a clinical cardiology specialist, with above-average Medicare volume (top 26% in WA), with low-engagement industry engagement in the top 10% of WA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reznicek experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Reznicek performed 499 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reznicek receive payments from pharmaceutical companies?
Yes. Dr. Reznicek received a total of $10,679 from 66 companies across 407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reznicek's costs compare to other urology physicians in Bellingham?
Dr. Reznicek's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reznicek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bellingham
Browse urology physicians in Bellingham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology